May 04, 2012 Domestic News Market Roundup
Piramal Healthcare Q4FY12 Consolidated YoY Net Loss at Rs 39 crore vs Indian Market
Pantaloon Retail Board approves issue of 81.6 lakh shares to Bennett & Nifty
Oil min to RIL -to disallow USD457 m of cost recovery for 2010-11, to disallow
USD778 m of cost recovery in 2011-12. RIL received notice on Wednesday,
RIL fined Rs 6600 crore for KG D6 output fall
Asian Market
Cipla Gets US FDA tentative nod for HIV-1 drug Viramune generic. Cuts price
of Generic Version Bayer’s cancer drug Nexavar prices by 75%
Cairn India to invest USD5 billion in Barmer block to increase output
Delhi High Court adjourns hearing in IGL vs PNGRB matter to May 8
Dr Reddys gets US nod for osteoporosis drug Boniva 150 mg generic
Pheonix Mills board clears raising Rs 1000 crore via QIP route
US & Europe
Bosch to invest Rs 300 crore in Nashik plant expansion
Mcnally Bharat Engineering receives 2 Orders worth Rs.177 crore from NTPC Nasdaq
and Unitech Hi-Tech (NTPC Thermal Project worth Rs 170 crore)
GAAR may be put off by a year, tax amt of Rs 10-15 crore may be the threshold FTSE 100
Taib Bank investment in Anantraj Industries could come under scanner of ED & CAC 40
International News Commodities
European Central Bank President Mario Draghi left open the option of further Gas (USD/MMBtu)
stimulus if the economy continues to deteriorate as investors await the outcome
U.K. commercial property values declined by 0.7% in the first three months of Copper (USD/lb)
2012, the second consecutive quarter of decline
The European Central Bank held interest rates at 1% and will resist calls to do Baltic Dry Index
more to fight the euro zone crisis, putting the onus on governments to foster
growth and head off anger over austerity policies
Currency Fund Flow ADR Value
query@kredentadvisors.com +91-33-40002461/62 Kredent Research Advisors Please see the disclosures on the last page For Private Circulation Only Sectoral Performance One Day Change Five Day Change
* Based on Kredent Proprietary Sectoral Index
Q4FY12 Result Estimation Net Sales (Rs. Crore) Net profit (Rs. Crore) Company Name Expected Expected Dividends Dividend Record/B.C Date F&O Scrips Cash Scrips Buy Back Open Offer % of Paid Up Kredent Research Advisors For Private Circulation Only Forthcoming Board Meetings F&O Scrips
Housing Development Finance Corporation Limited
Cash Scrips
The United Nilgiri Tea Estates Company Limited
Kesar Terminals & Infrastructure Limited
Kredent Research Advisors For Private Circulation Only NIFTY 50 Top Gainers NIFTY 50 Top Losers NSE Top Turnover - By Value (in millions) NSE Top Turnover - By Contracts (in millions) Turnover Turnover Most Active Calls - By Contracts Most Active Puts - By Contracts Strike Price Expiry Date Strike Price Expiry Date BSE SMALLCAP Upper Circuit BSE SMALLCAP Lower Circuit Kredent Research Advisors For Private Circulation Only DISCLOSURES:
This document was produced by Kredent Research Advisors Private Limited ‘Kredent’. The document is being furnished to Kredent clients for their information purposes only and is not an offer or the solicitation of an offer, to buy or sell a security. This document is not to be relied upon or used in substitution for the exercise of independent judgment.
Information and opinions contained herein have been compiled or arrived by Kredent from sources believed to be reliable, but Kredent has not independently verified the contents of this document. Accordingly, no representation or warranty, express or implied, is made as to and no reliance should be placed on the fairness, accuracy, completeness or correctness of the information and opinions contained in this document. Kredent accepts no liability for any loss arising from the use of this document or its contents or otherwise arising in connection therewith.
We and our affiliates, directors, and employees worldwide may: (a) from time to time, have long or short positions in, and buy or sell the securities thereof, of company (ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company (ies) discussed herein or have other potential conflict of interest with respect to any recommendation and related information and opinions.
It is being furnished to Kredent clients for their information purposes only and may not be reproduced or published in any media, website or otherwise, in part or as a whole, without the prior consent in writing of Kredent. Persons who receive this document should make themselves aware of and adhere to any such restrictions.
ADDRESS:
# 3, Pretoria Street, Kolkata – 700071
For further queries you can ask us at query@kredentadvisors.com Kredent Research Advisors For Private Circulation Only
Peer-Reviewed Published Papers, Abstracts, Letters on Exergen Temporal Artery Thermometry Al-Mukhaizeem F, Allen U, Komar L, et al (University of Toronto/Hospital for Sick Children). Validation of the temporal artery thermometry by its comparison with the esophageal method in children. Pediatric Academic Societies Annual Meeting, May 3-6, 2003, Seattle, WA Al-Mukhaizeem F, Allen U, Koma
Appendix Die Blut-Hirn-Schranke von Edwin H. Bessai - Die Blut-Hirn-Schranke der Gehirnkapillaren. Prodrugs, das Prodrug „Levodopa“ und „Levodopa-Präparate“ Warum die Ernährung bei der Einnahme von Levodopa-Präparaten eine Rolle spielt, wie deshalb die Ernährung gestaltet werden muss und wie Levodopa-Präparate eingenommen werden müssen. Das Gehirn mu